Peter G Stock

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Evolving clinical strategies for transplantation in the HIV-positive recipient
    Peter G Stock
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Transplantation 84:563-71. 2007
  2. ncbi The year in review--ATC 2002
    Peter G Stock
    Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA 94143 0780, USA
    Am J Transplant 3:373-80. 2003
  3. ncbi Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study
    Peter G Stock
    Department of Surgery, Division of Transplantation, University of California, San Francisco, California 94143 0780, USA
    Transplantation 76:370-5. 2003
  4. ncbi Beta-cell replacement for type I diabetes
    Peter G Stock
    Department of Surgery, Division of Transplantation, University of California, San Francisco, San Francisco, California 94143, USA
    Annu Rev Med 55:133-56. 2004
  5. pmc Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients
    Lynda A Frassetto
    1 Department of Medicine and Clinical Research Center, University of California, San Francisco, CA 2 Department of Surgery, University of California, San Francisco, CA 3 EMMES, Bethesda, MD 4 Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 5 Address correspondence to Leslie Z Benet, Ph D, UCSF Box 0912, San Francisco, CA 94143 0912
    Transplantation 97:702-7. 2014
  6. pmc Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
    Norah A Terrault
    University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Liver Transpl 18:716-26. 2012
  7. pmc Outcomes of kidney transplantation in HIV-infected recipients
    Peter G Stock
    University of California, San Francisco, San Francisco, CA 94143 0116, USA
    N Engl J Med 363:2004-14. 2010
  8. ncbi Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients
    Lynda Frassetto
    Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
    Transplantation 80:13-7. 2005
  9. pmc Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients
    Jack Harbell
    University of California, San Francisco, San Francisco, CA 94143 0470, USA
    Surgery 152:376-81. 2012
  10. ncbi BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant
    Gerald S Lipshutz
    University of California, Los Angeles, Department of Surgery, Los Angeles, CA, USA
    Am J Transplant 5:366-73. 2005

Research Grants

Detail Information

Publications34

  1. ncbi Evolving clinical strategies for transplantation in the HIV-positive recipient
    Peter G Stock
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Transplantation 84:563-71. 2007
    ..This overview will describe the evolving clinical strategies that have resulted in good outcomes after solid organ transplantation in the HIV-positive recipient...
  2. ncbi The year in review--ATC 2002
    Peter G Stock
    Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA 94143 0780, USA
    Am J Transplant 3:373-80. 2003
    ....
  3. ncbi Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study
    Peter G Stock
    Department of Surgery, Division of Transplantation, University of California, San Francisco, California 94143 0780, USA
    Transplantation 76:370-5. 2003
    ....
  4. ncbi Beta-cell replacement for type I diabetes
    Peter G Stock
    Department of Surgery, Division of Transplantation, University of California, San Francisco, San Francisco, California 94143, USA
    Annu Rev Med 55:133-56. 2004
    ..Widespread application of islet transplantation will depend on further improvements in selective immunosuppression, development of immunologic tolerance, and finding new sources of beta cells...
  5. pmc Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients
    Lynda A Frassetto
    1 Department of Medicine and Clinical Research Center, University of California, San Francisco, CA 2 Department of Surgery, University of California, San Francisco, CA 3 EMMES, Bethesda, MD 4 Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 5 Address correspondence to Leslie Z Benet, Ph D, UCSF Box 0912, San Francisco, CA 94143 0912
    Transplantation 97:702-7. 2014
    ....
  6. pmc Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
    Norah A Terrault
    University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Liver Transpl 18:716-26. 2012
    ..Our results indicate that HCV per se is not a contraindication to LT in HIV patients, but recipient and donor selection and the management of acute rejection strongly influence outcomes...
  7. pmc Outcomes of kidney transplantation in HIV-infected recipients
    Peter G Stock
    University of California, San Francisco, San Francisco, CA 94143 0116, USA
    N Engl J Med 363:2004-14. 2010
    ..The outcomes of kidney transplantation and immunosuppression in people infected with human immunodeficiency virus (HIV) are incompletely understood...
  8. ncbi Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients
    Lynda Frassetto
    Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
    Transplantation 80:13-7. 2005
    ....
  9. pmc Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients
    Jack Harbell
    University of California, San Francisco, San Francisco, CA 94143 0470, USA
    Surgery 152:376-81. 2012
    ..In this report, we examine the surgical safety and complications (SC) among 125 liver (L) and 150 kidney (K) HIV+ transplantation (TX) recipients in a prospective nonrandomized U.S. multicenter trial...
  10. ncbi BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant
    Gerald S Lipshutz
    University of California, Los Angeles, Department of Surgery, Los Angeles, CA, USA
    Am J Transplant 5:366-73. 2005
    ..The pancreas, however, is spared from evidence of infection, and no pancreatic rejection occurred when immunosuppression was decreased...
  11. pmc Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease
    Gregory L Szot
    Department of Internal Medicine, Diabetes Center, University of California San Francisco, San Francisco, CA, USA
    Transplantation 88:753-6. 2009
    ..Here, we describe the factors that we consider most important for achieving reproducible and clinically useable islet isolations using this product...
  12. doi HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation
    Lan T Vu
    Department of Surgery, University of California at San Francisco, San Francisco, CA 94143 0780, USA
    Arch Surg 146:824-9. 2011
    ....
  13. pmc Renal transplantation in patients with HIV
    Lynda A Frassetto
    Department of Medicine and Clinical Research Center, University of California, San Francisco, CA 94143, USA
    Nat Rev Nephrol 5:582-9. 2009
    ..It also describes the clinical concerns associated with the treatment of renal transplant recipients with HIV...
  14. ncbi Solid organ transplantation: referral, management, and outcomes in HIV-infected patients
    Michelle E Roland
    University of California, San Francisco, USA
    AIDS Read 16:664-8, 675-8. 2006
    ..Timely referral for transplant evaluation will prevent unnecessary mortality during the pre-transplant evaluation process...
  15. ncbi Solid organ transplantation is a reality for patients with HIV infection
    Michelle E Roland
    Department of Medicine, University of California, Positive Health Program AIDS Division at San Francisco General Hospital, Ward 84, Building 80, 995 Potrero Avenue, San Francisco, CA 94110, USA
    Curr HIV/AIDS Rep 3:132-8. 2006
    ..Because important patient selection and clinical management questions remain, it is critical that ongoing studies are completed quickly...
  16. ncbi Liver transplantation in HIV-infected recipients
    Michelle E Roland
    Department of Medicine, Positive Health Program, AIDS Division, University of California, San Francisco, CA, USA
    Semin Liver Dis 26:273-84. 2006
    ....
  17. ncbi Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation
    Norah A Terrault
    Department of Medicine, University of California at San Francisco, San Francisco, CA 64143 0538, USA
    Liver Transpl 12:801-7. 2006
    ..In HIV-HBV coinfected patients undergoing LT, HBV recurrence is successfully prevented with combination prophylaxis using HBIG and antivirals...
  18. ncbi Review of solid-organ transplantation in HIV-infected patients
    Michelle E Roland
    Department of Medicine, University of California, San Francisco, California, USA
    Transplantation 75:425-9. 2003
  19. doi Malignancy in the HIV-infected patients undergoing liver and kidney transplantation
    Nicholas N Nissen
    Cedars Sinai Medical Center, West Hollywood, California, USA
    Curr Opin Oncol 24:517-21. 2012
    ..The addition of transplant immunosuppressants to an already immunocompromised state, however, may increase the risk of malignancy...
  20. ncbi Liver and kidney transplantation in HIV-infected patients
    Clara C Tan-Tam
    Department of Surgery, University of California, San Francisco, CA, USA
    AIDS Rev 11:190-204. 2009
    ..This review examines the current clinical strategies and issues surrounding liver and kidney transplantation in HIV-infected patients...
  21. ncbi Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts
    George J Chang
    Division of Transplantation Surgery, Department of Surgery, University of California, San Francisco School of Medicine, 94143, USA
    Surgery 132:149-56. 2002
    ..The purpose of this study was to modulate the immune response of rat liver transplant recipients by adenovirus-mediated gene transfer of CD40Ig, a secretable fusion protein designed to block the CD40-CD154 T-cell costimulation pathway...
  22. ncbi The rationale for the new deceased donor pancreas allocation schema
    Mark D Stegall
    Department of Surgery, Division of Transplantation Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Transplantation 83:1156-61. 2007
    ..To ensure the continued success of whole organ pancreas and islet transplantation, deceased donor pancreas allocation policy must continue to evolve...
  23. doi Predictors associated with terminal renal function in deceased organ donors in the intensive care unit
    Annabel Blasi-Ibanez
    Department of Anesthesia and Perioperative Care, University of California San Francisco, California, 94143 0648, USA
    Anesthesiology 110:333-41. 2009
    ..Factors determining renal function at organ recovery in deceased kidney donors are not well established...
  24. doi Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade
    Andrew M Posselt
    Transplant Division, Department of Surgery, University of California, San Francisco, San Francisco, CA 94143 0790, USA
    Transplantation 90:1595-601. 2010
    ....
  25. ncbi Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients
    Michelle E Roland
    Positive Health Program Department of Medicine University of California, San Francisco Ward 84, San Francisco General Hospital 995 Potrero Ave San Francisco, CA 94110, USA
    Arch Intern Med 163:1773-8. 2003
  26. ncbi Successful long-term outcomes using pediatric en bloc kidneys for transplantation
    Jade S Hiramoto
    Department of Surgery, University of California San Francisco, USA
    Am J Transplant 2:337-42. 2002
    ..The objective of our study was to determine whether acceptable long-term graft survival and function can be achieved using pediatric en bloc renal transplants by employing specific immunologic and selection strategies...
  27. ncbi Ethical issues in split versus whole liver transplantation
    Anntim Vulchev
    Department of Surgery, Division of Transplantation, University of California, San Francisco, San Francisco, CA, USA
    Am J Transplant 4:1737-40. 2004
    ..This essay explores the ethical issues involved in the allocation of split livers, and proposes general policy guidelines for the allocation of split versus whole liver transplants...
  28. doi Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequence
    Rita A Mukhtar
    Department of Surgery, University of California, San Francisco, CA 94143, USA
    J Pediatr Surg 44:e31-3. 2009
    ..Pediatr Dev Pathol 1998;1:281-288). We report a case of long-term survival, currently to 25 months of age, and renal transplantation in a monochorionic, diamniotic twin girl with CDS...
  29. ncbi Current status of kidney and pancreas transplantation in the United States, 1994-2003
    Gabriel M Danovitch
    David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
    Am J Transplant 5:904-15. 2005
    ..The percentage of Hispanic/Latino recipients increased from 5% to 9% over the same period...
  30. ncbi Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV
    Scott D Halpern
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, 19104 6021, USA
    Am J Transplant 5:1319-25. 2005
    ..HIV-infected patients should have equal access to organs unless or until evidence emerges that they fare substantially worse than other potential recipients...
  31. ncbi [Comprehensive guidelines translate research findings into clinical policy for HIV-infected transplant candidates and recipients]
    Michelle E Roland
    Enferm Infecc Microbiol Clin 23:331-4. 2005
  32. ncbi Rapid deterioration of HIV co-infected patients waiting for liver transplantation is not predicted by MELD
    Peter G Stock
    Liver Transpl 11:1315-7. 2005
  33. ncbi Management of lymphoceles after renal transplantation: laparoscopic versus open drainage
    T Florian Fuller
    Department of Urology, Charite Hospital, Humboldt University Berlin, Germany
    J Urol 169:2022-5. 2003
    ..In this single center study we retrospectively reviewed our results of the surgical management of post-transplant lymphoceles, assessing indication and outcome of laparoscopic versus open drainage...
  34. ncbi End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation
    T Florian Fuller
    Department of Urology, Charite University Hospital, Campus Charite Mitte, Schumannstrasse 20 21, 10117 Berlin, Germany
    J Urol 174:2284-8. 2005
    ..We evaluated the indications for and outcome of pre-transplant, concomitant and post-transplant native nephrectomy in patients with end stage polycystic kidney disease (PCKD)...

Research Grants2